1. AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE. (September 2021) Authors: Macaluso, F.S.; Cappello, M.; Crispino, F.; Grova, M.; Privitera, A.C.; Piccillo, G.; Magnano, A.; Ferracane, C.; Belluardo, N.; Giangreco, E.; Fries, W.; Viola, A.; Di Mitri, R.; Mocciaro, F.; Camilleri, S.; Garufi, S.; Renna, S.; Casà, A.; Maida, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501. (September 2021) Authors: Macaluso, F.S.; Cappello, M.; Busacca, A.; Fries, W.; Viola, A.; Costantino, G.; Magnano, A.; Vinci, E.; Ferracane, C.; Privitera, A.C.; Piccillo, G.; Belluardo, N.; Giangreco, E.; Romano, C.; Citrano, M.; Graziano, F.; Garufi, S.; Bertolami, C.; Ventimiglia, M.; Scrivo, B. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC.02.3 A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB, ADALIMUMAB, AND GOLIMUMAB IN PATIENTS WITH ULCERATIVE COLITIS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD). (1st October 2020) Authors: Macaluso, F.S.; Ventimiglia, M.; Fries, W.; Viola, A.; Cappello, M.; Scrivo, B.; Magnano, A.; Pluchino, D.; Camilleri, S.; Garufi, S.; Di Mitri, R.; Mocciaro, F.; Magrì, G.; Ferracane, C.; Citrano, M.; Graziano, F.; Bertolami, C.; Renna, S.; Orlando, R.; Rizzuto, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC.05.3 NERD AND PH CYCLICAL FLUCTUATION: PROPOSED OF THE IDEAL DIAGNOSTIC ALGORITHM. (24th February 2016) Authors: Scarpulla, G.; Scalisi, G.; La Ferrera, G.; Garufi, S.; Manganaro, M.; Camilleri, S. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 2 Page Start: e87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN'S DISEASE. (May 2022) Authors: Macaluso, F.S.; Grova, M.; Saladino, M.; Demarzo, M.G.; Privitera, A.C.; Giangreco, E.; Garufi, S.; Renna, S.; Casà, A.; Ventimiglia, M.; Cappello, M.; Fries, W.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.12.1 SPOSIB SB2 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2. (1st October 2020) Authors: Macaluso, F.S.; Fries, W.; Viola, A.; Centritto, A.; Cappello, M.; Giuffrida, E.; Privitera, A.C.; Piccillo, G.; Magnano, A.; Vinci, E.; Vassallo, R.; Trovatello, A.; Belluardo, N.; Giangreco, E.; Camilleri, S.; Garufi, S.; Bertolami, C.; Ventimiglia, M.; Renna, S.; Orlando, R. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS. (25th March 2019) Authors: Macaluso, F.S.; Cappello, M.; Giuffrida, E.; Fries, W.; Centritto, A.; Privitera, A.C.; Inserra, G.; Vassallo, R.; Magnano, A.; Vinci, E.; Garufi, S.; Ventimiglia, M.; Renna, S.; Orlando, R.; Rizzuto, G.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.13.3 EFFECTIVENESS AND TOLERABILITY OF VERY LOWVOLUME PREPARATION FOR COLONOSCOPY: A PROSPECTIVE, MULTICENTER STUDY. (25th March 2019) Authors: Maida, M.; Morreale, G.; Sinagra, E.; Manganaro, M.; Schillaci, D.; Garufi, S.; Cipolla, A. Cirrone; Camilleri, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P.02.27 SAFETY PROFILE OF ADALIMUMAB THERAPY IN PREGNANCY: A SINGLE CENTER EXPERIENCE. Issue 2 (15th March 2018) Authors: Garufi, S.; Maida, M.; Fiorentini, T.; Speciale, A.; Taci, A.; Camilleri, S.; Manganaro, M.; Morreale, G.C.; Scarpulla, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P.05.51 REFRACTORY GAVE TREATED WITH RADIOFREQUENCY ABLATION BY THROUGH-THE-SCOPE CATHETER: THREE CASES OF COMPLETE RESPONSE. (25th March 2019) Authors: Maida, M.; Morreale, G.; Scarpulla, G.; Manganaro, M.; Garufi, S.; Camilleri, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗